Literature DB >> 3687818

Determinants of vitamin D status in patients with hip fracture and in elderly control subjects.

P Lips1, F C van Ginkel, M J Jongen, F Rubertus, W J van der Vijgh, J C Netelenbos.   

Abstract

The factors that influence vitamin D status were investigated in 125 patients with hip fracture and in 74 elderly control subjects. The serum concentrations of 25-hydroxyvitamin D [25(OH)D] varied with sunshine score and were paralleled by serum 1,25-dihydroxyvitamin D [1,25(OH)2D]. The control subjects showed a higher sunshine score and higher serum 24(OH)D levels than the patients with hip fracture. Dietary vitamin D intake was similar in both groups (mean 115 IU/d). A positive correlation between vitamin D intake and serum 25(OH)D was observed in the patients with low sunshine exposure. It appeared from this relation that dietary vitamin D intake should be approximately 300 IU/d to maintain an adequate serum (25(OH)D concentration. Vitamin D status was very poor in patients who were institutionalized before hip fracture. Multiple regression analysis on serum 25(OH)D confirmed the primary role of sunshine exposure as determinant of vitamin D status. The principal determinants of serum 1,25(OH)2D were serum 25(OH)D, serum creatinine, and serum phosphate.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3687818     DOI: 10.1093/ajcn/46.6.1005

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  38 in total

1.  Bone density parathyroid hormone and 25-hydroxyvitamin D concentrations in middle aged women.

Authors:  K T Khaw; M J Sneyd; J Compston
Journal:  BMJ       Date:  1992-08-01

2.  Lack of in vitro evidence for storage of 1,25-dihydroxycholecalciferol (1,25(OH)2D3) and 1,25(OH)2D3 binding protein in skeletal matrix.

Authors:  S Boonen; J Aerssens; I Jans; E Van Herck; I Vandewal; J Peeters; R Van den Eynde; J Dequeker; R Bouillon
Journal:  Calcif Tissue Int       Date:  1996-12       Impact factor: 4.333

3.  Vitamin D status among patients with hip fracture and elderly control subjects in Yekaterinburg, Russia.

Authors:  S Bakhtiyarova; O Lesnyak; N Kyznesova; M A Blankenstein; P Lips
Journal:  Osteoporos Int       Date:  2005-11-19       Impact factor: 4.507

Review 4.  The pathogenesis and treatment of hip fractures.

Authors:  P Lips; K J Obrant
Journal:  Osteoporos Int       Date:  1991-09       Impact factor: 4.507

5.  Vitamin D intake and status in Irish elderly women and adolescent girls.

Authors:  D McCarthy; A Collins; M O'Brien; C Lamberg-Allardt; J Jakobsen; J Charzewska; M Kiely; A Flynn; K D Cashman
Journal:  Ir J Med Sci       Date:  2006 Apr-Jun       Impact factor: 1.568

Review 6.  Vitamin D and analogues in renal bone disease and implications for osteoporosis.

Authors:  J A Kanis; E V McCloskey; M N Beneton
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

7.  Efficacy of different doses and time intervals of oral vitamin D supplementation with or without calcium in elderly nursing home residents.

Authors:  V Chel; H A H Wijnhoven; J H Smit; M Ooms; P Lips
Journal:  Osteoporos Int       Date:  2007-09-14       Impact factor: 4.507

8.  Calciotropic hormones in elderly people with and without hip fracture.

Authors:  C L Benhamou; D Tourliere; J B Gauvain; G Picaper; M Audran; P Jallet
Journal:  Osteoporos Int       Date:  1995-03       Impact factor: 4.507

9.  Determinants of serum 25 hydroxyvitamin D levels in a nationwide cohort of blacks and non-Hispanic whites.

Authors:  Jacqueline Chan; Karen Jaceldo-Siegl; Gary E Fraser
Journal:  Cancer Causes Control       Date:  2009-12-11       Impact factor: 2.506

Review 10.  Vitamin D supplementation in older adults: searching for specific guidelines in nursing homes.

Authors:  Y Rolland; P de Souto Barreto; G Abellan Van Kan; C Annweiler; O Beauchet; H Bischoff-Ferrari; G Berrut; H Blain; M Bonnefoy; M Cesari; G Duque; M Ferry; O Guerin; O Hanon; B Lesourd; J Morley; A Raynaud-Simon; G Ruault; J-C Souberbielle; B Vellas
Journal:  J Nutr Health Aging       Date:  2013-04       Impact factor: 4.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.